Article Information
History
- June 23, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Jennifer Hicks1,2,*,
- Carleen Klumpp-Thomas3,2,*,
- Heather Kalish1,2,*,
- Anandakumar Shunmugavel2,
- Jennifer Mehalko4,
- John-Paul Denson4,
- Kelly Snead4,
- Matthew Drew4,
- Kizzmekia Corbett5,
- Barney Graham5,
- Matthew D Hall3,
- Matthew J Memoli6,
- Dominic Esposito4 and
- Kaitlyn Sadtler2,†
- 1Trans-NIH Shared Resource on Biomedical Engineering and Physical Science, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda MD 20894
- 2Section on Immuno-Engineering, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda MD 20892
- 3National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD, 20850
- 4Protein Expression Laboratory, NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702
- 5Vaccine Research Center, National Institute for Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892
- 6LID Clinical Studies Unit, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute for Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20894
- ↵†to whom correspondence should be addressed: kaitlyn.sadtler{at}nih.gov
↵* these authors contributed equally to this work
Posted June 23, 2020.
Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses
